Hrt Financial LP Immunity Bio, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$4.82 - $9.15 $326,709 - $620,205	67,782 New	67,782 $428,000
Q1 2023 May 12, 2023	BUY	$1.35 - $4.78 $94,348 - $334,064	69,888 New	69,888 $127,000
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $45,225 - $103,612	16,875 Added 44.59%	54,717 $203,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $191,102 - $284,950	37,842 New	37,842 $212,000
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $1.26 Million - $2.1 Million	-93,764 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $1.2 Million - $3.96 Million	93,764 New	93,764 $2.23 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.